Galantamine Extended-Release Capsules
DEFINITION
Galantamine Extended-Release Capsules contain galantamine hydrobromide (C17H21NO3·HBr) equivalent to NLT 90.0% and NMT 110.0% of the labeled amount of galantamine (C17H21NO3).
USP REFERENCE STANDARDS FOR PURCHASE
USP Galantamine Hydrobromide RSUSP Galantamine Hydrobromide Related Compounds Mixture RS